Black Hills Regional Eye Institute

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 859 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +4

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

Quan Dong Nguyen, Syed Mahmood Shah, Afsheen Khwaja et al. · Ophthalmology · 2010 · 529 citations

Metabolic Syndrome, Diabetes Management, Diabetes +4

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

David Liao, F Grossi, Delphine El Mehdi et al. · Ophthalmology · 2019 · 491 citations · Full text

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

Prema Abraham, Huibin Yue, Laura Wilson · American Journal of Ophthalmology · 2010 · 443 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +5

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

Quan Dong Nguyen, Syed Mahmood Shah, Jeffrey S. Heier et al. · Ophthalmology · 2009 · 343 citations

Metabolic Syndrome, Diabetes Management, Six Months +5